Rapid Micro Biosystems

Rapid Micro Biosystems is a life‑sciences technology company that delivers automation solutions for the manufacturing of biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct® platform replaces manual microbiology testing, bringing quality‑control directly to production lines to accelerate, increase accuracy, and maintain data‑integrity compliance. The company offers rapid detection, environmental monitoring, bioburden and sterility testing, and full QC automation, helping clients achieve faster, more reliable product release. With a customer‑driven, inclusive culture and a global footprint that spans the U.S., Switzerland, Germany, and the Netherlands, Rapid Micro Biosystems partners with manufacturers to improve patient outcomes through smarter, faster manufacturing.